ICU Medical, Inc. (NASDAQ:ICUI) Director Robert S. Swinney sold 4,477 shares of the business’s stock in a transaction dated Thursday, July 20th. The stock was sold at an average price of $175.00, for a total transaction of $783,475.00. Following the sale, the director now owns 23,293 shares in the company, valued at $4,076,275. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of ICU Medical, Inc. (ICUI) traded up 1.24% during trading on Thursday, hitting $175.55. 79,856 shares of the stock traded hands. The company has a 50 day moving average of $170.57 and a 200-day moving average of $155.16. The company has a market cap of $3.48 billion, a PE ratio of 31.20 and a beta of 0.37. ICU Medical, Inc. has a 1-year low of $111.73 and a 1-year high of $176.50.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, May 10th. The medical instruments supplier reported $1.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.45 by $1.23. The business had revenue of $247.74 million for the quarter, compared to the consensus estimate of $237.12 million. ICU Medical had a net margin of 18.76% and a return on equity of 9.63%. The firm’s quarterly revenue was up 175.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.26 EPS. On average, equities analysts anticipate that ICU Medical, Inc. will post $4.14 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/07/20/icu-medical-inc-nasdaqicui-director-robert-s-swinney-sells-4477-shares.html.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Creative Planning increased its position in ICU Medical by 315.6% in the first quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 505 shares during the last quarter. Ameritas Investment Partners Inc. acquired a new position in ICU Medical during the first quarter worth about $194,000. Sawgrass Asset Management LLC acquired a new position in ICU Medical during the first quarter worth about $229,000. Janney Montgomery Scott LLC increased its position in ICU Medical by 0.4% in the first quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock worth $245,000 after buying an additional 7 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its position in ICU Medical by 2.5% in the first quarter. State of Alaska Department of Revenue now owns 1,640 shares of the medical instruments supplier’s stock worth $250,000 after buying an additional 40 shares during the last quarter. Institutional investors own 77.90% of the company’s stock.

A number of analysts have commented on the stock. BidaskClub downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “strong-buy” rating and set a $195.00 price target on the stock in a research report on Wednesday, July 12th. Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. Finally, Roth Capital downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a research report on Thursday, May 11th. They noted that the move was a valuation call. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. ICU Medical currently has an average rating of “Hold” and an average price target of $156.00.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.